INHIBITEURS SÉLECTIFS DE L'ISOFORME TGFBETA1 ET UTILISATION ASSOCIÉE

Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHAPRON, Christopher, WAWERSIK, Stefan, STEIN, Caitlin, BUCKLER, Alan, COOPER, Anthony, LIN, Susan, SCHURPF, Thomas, DAGBAY, Kevin B, CAPILI, Allan, JACKSON, Justin W, DATTA, Abhishek, SALOTTO, Matthew, AVERY, Andrew, MARTIN, Constance, CARVEN, Gregory J, LITTLEFIELD, Christopher
Format:	Patent
Sprache:	fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.